{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:49:38Z","timestamp":1770752978463,"version":"3.50.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/ijg.0b013e318166656d","type":"journal-article","created":{"date-parts":[[2008,12,17]],"date-time":"2008-12-17T08:30:08Z","timestamp":1229502608000},"page":"662-666","source":"Crossref","is-referenced-by-count":15,"title":["Long-term Effects of Latanoprost Monotherapy on Intraocular Pressure in Japanese Glaucoma Patients"],"prefix":"10.1097","volume":"17","author":[{"given":"Kenji","family":"Kashiwagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Tsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Tsukahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210208","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00055735-200304000-00001","article-title":"Update on prostaglandin analogs","volume":"14","author":"Hylton","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"key":"R2-10-20210208","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/S0039-6257(02)00308-9","article-title":"Current status of prostaglandin therapy: latanoprost and unoprostone","volume":"47","author":"Susanna","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R3-10-20210208","first-page":"1134","article-title":"From PGF (2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture","volume":"42","author":"Stjernschantz","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-10-20210208","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/08820539909061464","article-title":"Prostaglandin analogs in the treatment of glaucoma","volume":"14","author":"Hejkal","year":"1999","journal-title":"Semin Ophthalmol"},{"key":"R5-10-20210208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0039-6257(83)90138-8","article-title":"Shortterm \u201cescape\u201d and longterm \u201cdrift.\u201d The dissipation effects of the beta adrenergic blocking agents","volume":"28","author":"Boger","year":"1983","journal-title":"Surv Ophthalmol"},{"key":"R6-10-20210208","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archopht.1981.03930010102012","article-title":"Long-term drift and continued efficacy after multiyear timolol therapy","volume":"99","author":"Steinert","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"R7-10-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1034\/j.1600-0420.2000.078001071.x","article-title":"Latanoprost: experience of 2-year treatment in Scandinavia","volume":"78","author":"Alm","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R8-10-20210208","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0039-6257(02)00301-6","article-title":"The effect of latanoprost on intraocular pressure during 2 years of treatment","volume":"47","author":"Hedman","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R9-10-20210208","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/bjo.2003.020826","article-title":"Long term effect of latanoprost on intraocular pressure in normal tension glaucoma","volume":"88","author":"Ang","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R10-10-20210208","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10384-005-0288-7","article-title":"Incidence of a latanoprost-induced increase in iris pigmentation in Japanese eyes","volume":"50","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"R11-10-20210208","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10384-003-0039-6","article-title":"A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost","volume":"48","author":"Chiba","year":"2004","journal-title":"Jpn J Ophthalmol"},{"key":"R12-10-20210208","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.eye.6701663","article-title":"Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes","volume":"19","author":"Chou","year":"2005","journal-title":"Eye"},{"key":"R13-10-20210208","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0008-4182(02)80004-7","article-title":"Quantitative analysis of eyelash lengthening following topical latanoprost therapy","volume":"37","author":"Sugimoto","year":"2002","journal-title":"Can J Ophthalmol"},{"key":"R14-10-20210208","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1034\/j.1600-0420.80.s236.36.x","article-title":"Eyelash hypertrichosis induced by topical latanoprost: 6-month follow-up study","volume":"236","author":"Stecchi","year":"2002","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"R15-10-20210208","first-page":"134","article-title":"A case of cystoid macular edema associated with latanoprost ophthalmic solution","volume":"49","author":"Tokunaga","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"R16-10-20210208","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archopht.123.2.186","article-title":"Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial","volume":"123","author":"Arcieri","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R17-10-20210208","first-page":"342","article-title":"Long-term effects of latanoprost on visual fields in eyes with normal-tension glaucoma-five-year follow-up-","volume":"56","author":"Ogawa","year":"2005","journal-title":"Folia Ophthalmol Jpn"},{"key":"R18-10-20210208","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.eye.6701373","article-title":"A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients","volume":"18","author":"Tomita","year":"2004","journal-title":"Eye"},{"key":"R19-10-20210208","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","article-title":"The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R20-10-20210208","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0039-6257(97)80016-1","article-title":"Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States","volume":"41","author":"Alm","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"R21-10-20210208","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00061198-200312000-00004","article-title":"Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma","volume":"12","author":"Camras","year":"2003","journal-title":"J Glaucoma"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IJG.0b013e318166656d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:56:11Z","timestamp":1620953771000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00061198-200812000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e318166656d","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}